These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23228878)

  • 1. Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.
    Georgiadou D; Chroni A; Drosatos K; Kypreos KE; Zannis VI; Stratikos E
    Atherosclerosis; 2013 Feb; 226(2):385-91. PubMed ID: 23228878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.
    Drosatos K; Kypreos KE; Zannis VI
    Biochemistry; 2007 Aug; 46(33):9645-53. PubMed ID: 17655277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
    Rye KA; Bright R; Psaltis M; Barter PJ
    J Lipid Res; 2006 May; 47(5):1025-36. PubMed ID: 16452453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
    Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
    J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism.
    Acharya P; Segall ML; Zaiou M; Morrow J; Weisgraber KH; Phillips MC; Lund-Katz S; Snow J
    Biochim Biophys Acta; 2002 Sep; 1584(1):9-19. PubMed ID: 12213488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aminoterminal 1-185 domain of human apolipoprotein E suffices for the de novo biogenesis of apoE-containing HDL-like particles in apoA-I deficient mice.
    Petropoulou PA; Gantz DL; Wang Y; Rensen PC; Kypreos KE
    Atherosclerosis; 2011 Nov; 219(1):116-23. PubMed ID: 21802082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.
    Argyri L; Dafnis I; Theodossiou TA; Gantz D; Stratikos E; Chroni A
    J Biol Chem; 2014 May; 289(18):12931-45. PubMed ID: 24644280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE.
    Peng D; Song C; Reardon CA; Liao S; Getz GS
    J Neurochem; 2003 Sep; 86(6):1391-402. PubMed ID: 12950448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical properties of apolipoprotein E4 variants: implications in molecular mechanisms of correction of hypertriglyceridemia.
    Gorshkova IN; Kypreos KE; Gantz DL; Zannis VI; Atkinson D
    Biochemistry; 2008 Nov; 47(47):12644-54. PubMed ID: 18959431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
    Kypreos KE; van Dijk KW; Havekes LM; Zannis VI
    J Biol Chem; 2005 Feb; 280(8):6276-84. PubMed ID: 15576362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
    Weers PM; Narayanaswami V; Choy N; Luty R; Hicks L; Kay CM; Ryan RO
    Biophys Chem; 2003; 100(1-3):481-92. PubMed ID: 12646385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
    Settasatian N; Barter PJ; Rye KA
    J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.
    Clément-Collin V; Barbier A; Dergunov AD; Visvikis A; Siest G; Desmadril M; Takahashi M; Aggerbeck LP
    Biophys Chem; 2006 Jan; 119(2):170-85. PubMed ID: 16125836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects.
    Ikewaki K; Zech LA; Brewer HB; Rader DJ
    J Lab Clin Med; 2002 Nov; 140(5):369-74. PubMed ID: 12434139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4.
    Hatters DM; Peters-Libeu CA; Weisgraber KH
    J Biol Chem; 2005 Jul; 280(28):26477-82. PubMed ID: 15890642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.
    Li MY; Kwok MK; Schooling CM
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.